MA39860A - Polymorphic forms of furazidin - Google Patents
Polymorphic forms of furazidinInfo
- Publication number
- MA39860A MA39860A MA039860A MA39860A MA39860A MA 39860 A MA39860 A MA 39860A MA 039860 A MA039860 A MA 039860A MA 39860 A MA39860 A MA 39860A MA 39860 A MA39860 A MA 39860A
- Authority
- MA
- Morocco
- Prior art keywords
- furazidin
- polymorphic forms
- nitrofuran
- imidazolidin
- ylidene
- Prior art date
Links
- DECBQELQORZLLP-UAIOPKHMSA-N 1-[(e)-[(e)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione Chemical compound O1C([N+](=O)[O-])=CC=C1\C=C\C=N\N1C(=O)NC(=O)C1 DECBQELQORZLLP-UAIOPKHMSA-N 0.000 title abstract 3
- 229960002375 furazidin Drugs 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention relates to the crystalline forms of furazidin (1-{[(1e,2e)-3-(5-nitrofuran-2-yl)prop-2-ene-1-ylidene]amino}imidazolidin-2,4-dione) and methods of preparation thereof
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LVP-14-44A LV15081B (en) | 2014-05-29 | 2014-05-29 | Polymorphic forms of furazidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA39860A true MA39860A (en) | 2015-12-03 |
Family
ID=53969380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA039860A MA39860A (en) | 2014-05-29 | 2015-05-27 | Polymorphic forms of furazidin |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3148988A1 (en) |
| EA (1) | EA201692217A1 (en) |
| LV (1) | LV15081B (en) |
| MA (1) | MA39860A (en) |
| UA (1) | UA115290C2 (en) |
| WO (1) | WO2015181741A1 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2990402A (en) | 1958-10-07 | 1961-06-27 | Smith Kline French Lab | Preparation of 1-aminohydantoin derivatives |
| FR1489091A (en) | 1966-05-09 | 1967-07-21 | Clin Byla Ets | New hydantoins and their preparation |
| WO1997019930A1 (en) | 1995-11-27 | 1997-06-05 | Lonza Ag | Process for producing 1-aminohydantoin |
| PL185120B1 (en) | 1997-03-17 | 2003-02-28 | Adamed Sp Z Oo | Method of obtaining 1-{[3-(5-nitro-2-furyl)-2-propenyliden]-amino}imidazolydin-2,4-dione |
-
2014
- 2014-05-29 LV LVP-14-44A patent/LV15081B/en unknown
-
2015
- 2015-05-27 WO PCT/IB2015/053968 patent/WO2015181741A1/en not_active Ceased
- 2015-05-27 EA EA201692217A patent/EA201692217A1/en unknown
- 2015-05-27 MA MA039860A patent/MA39860A/en unknown
- 2015-05-27 UA UAA201611302A patent/UA115290C2/en unknown
- 2015-05-27 EP EP15753991.7A patent/EP3148988A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP3148988A1 (en) | 2017-04-05 |
| UA115290C2 (en) | 2017-10-10 |
| LV15081A (en) | 2015-12-20 |
| LV15081B (en) | 2016-11-20 |
| WO2015181741A1 (en) | 2015-12-03 |
| EA201692217A1 (en) | 2017-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268625A (en) | Amino pyrimidine compounds useful as ssao inhibitors | |
| PT3534743T (en) | Footwear, and methods of preparing same | |
| ZA201906464B (en) | Crystalline forms of (s)-afoxolaner | |
| EP3310358A4 (en) | Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders | |
| EP3185655B8 (en) | Method for the individual encoding of metal-ceramic substrates | |
| IL273896A (en) | Crystalline forms of 3-substituted 1,2,4-oxadiazole | |
| WO2014174456A3 (en) | Polymorphic forms of nilotinib hydrochloride | |
| EP3399996A4 (en) | Methods of administering hepcidin | |
| ZA201808014B (en) | Adenine derivatives as protein kinase inhibitors | |
| EP3250562A4 (en) | Crystalline forms of c21h22ci2n4o2 | |
| IL293192A (en) | Methods of preparing indolinobenzodiazepine derivatives | |
| EP3530650A4 (en) | Crystalline form of (r)-4-hydroxy-2-oxo-1-pyrrolidineacetamide, preparation method therefor and use thereof | |
| EP3323811A4 (en) | Production method for nitrogen-containing heterocyclic compound, and intermediate of said nitrogen-containing heterocyclic compound | |
| EP3262025A4 (en) | Novel intermediates for preparing dpp-iv inhibitors, preparing method thereof and preparing method of dpp-iv inhibitors using the same | |
| MX2019010640A (en) | Crystalline forms of obeticholic acid. | |
| EP3216791A4 (en) | Polymorphic substance of yonkenafil hydrochloride, preparation method therefor, and composition and use thereof | |
| EP3247399A4 (en) | Crystalline forms of efinaconazole | |
| EP3181556A4 (en) | Micromolecule compound, method of synthesis and application thereof | |
| EP3277665A4 (en) | Indole analogs as 5-oxo-ete receptor antagonists and method of use thereof | |
| EP3344593A4 (en) | Compositions and methods for well cementing | |
| ZA201908372B (en) | Pyridoquinazoline derivatives useful as protein kinase inhibitors | |
| UA115290C2 (en) | Polymorphic forms of furazidin | |
| IL265634A (en) | Novel 5-substituted imidazolylmethyl derivatives | |
| IT201700050223A1 (en) | PROCEDURE FOR THE PREPARATION OF CRYSTALLINE DEXLANSOPRAZOLE | |
| EP3110799A4 (en) | Heterocyclic inhibitors of the sodium channel |